A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.

A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.

Dr. Weickert will present Pacylex at the OBIO® Investment Summit and Early Technology Showcase February 5-7, 2025, at the Arcadian Court & Loft, Toronto Mr. Kamdar will present Pacylex at the PWMC ...

Chief R&D and commercial officer Najat Khan, PhD, tells GEN Edge the company aims to improve design of studies, accelerate enrollment, and enhance evidence generation.

Among patients with advanced PIK3CA-mutated, HR-positive/HER2-negative breast cancer, Itovebi-based treatment generated ...

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.

Roche’s freshly approved PI3K inhibitor Itovebi can help extend the lives of certain patients with breast cancer when used in ...

Cofounded by Dr. Siddhartha Mukherjee and Reid Hoffman, Manas AI leverages proprietary AI, generative computational chemistry ...

Anime enthusiasts in Japan can watch I'm Getting Married to a Girl I Hate in My Class episode 2 on Tokyo MX, BS11, Tochigi TV, Gunma TV, and other channels. On the other hand, the episode will be ...

A Python interface for ab initio path integral molecular dynamics simulations (and more). i-PI is a Python server (that does not need to be compiled and only requires ...

The PI3K inhibitor market is becoming increasingly ... positions it as a potentially best-in-class PI3Ka inhibitor. This superior efficacy compared to current standards of care could drive strong ...